In the TLS, tumor-associated antigens trigger B cell transformation into an effector/memory phenotype that produces antibodies, and presents tumor antigens to T cells, thereby boosting the prognostic function of CD8+ T cells and promoting T cell growth (113). The gene discussed is CD8A; the disease is neoplasm.